NEPHROS INC's ticker is NEPH and the CUSIP is 640671400. A total of 18 filers reported holding NEPHROS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67 | -4.3% | 45,341 | 0.0% | 0.04% | -2.2% |
| Q2 2023 | $70 | +29.6% | 45,341 | -9.9% | 0.04% | +25.0% |
| Q1 2023 | $54 | -6.9% | 50,341 | 0.0% | 0.04% | -10.0% |
| Q4 2022 | $58 | -99.9% | 50,341 | 0.0% | 0.04% | +21.2% |
| Q3 2022 | $46,000 | -11.5% | 50,341 | +48.1% | 0.03% | 0.0% |
| Q2 2022 | $52,000 | -50.0% | 34,000 | +43.4% | 0.03% | -41.1% |
| Q1 2022 | $104,000 | +15.6% | 23,712 | +56.0% | 0.06% | +9.8% |
| Q4 2021 | $90,000 | +20.0% | 15,200 | +78.8% | 0.05% | +13.3% |
| Q3 2021 | $75,000 | -12.8% | 8,500 | 0.0% | 0.04% | -15.1% |
| Q2 2021 | $86,000 | -7.5% | 8,500 | -39.4% | 0.05% | -8.6% |
| Q1 2021 | $93,000 | -24.4% | 14,019 | -1.9% | 0.06% | -29.3% |
| Q4 2020 | $123,000 | +7.9% | 14,290 | -9.0% | 0.08% | -7.9% |
| Q3 2020 | $114,000 | +4.6% | 15,700 | +21.2% | 0.09% | +4.7% |
| Q2 2020 | $109,000 | +32.9% | 12,957 | 0.0% | 0.08% | +25.0% |
| Q1 2020 | $82,000 | +39.0% | 12,957 | +119.3% | 0.07% | +100.0% |
| Q4 2019 | $59,000 | – | 5,908 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEXFORD CAPITAL LP | 3,395,579 | $21,391,000 | 7.91% |
| BARD ASSOCIATES INC | 207,569 | $2,640,000 | 1.94% |
| Parkman Healthcare Partners LLC | 251,366 | $1,584,000 | 0.73% |
| Cowen Prime Services LLC | 154,800 | $975,000 | 0.60% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 12,957 | $82,000 | 0.07% |
| INGALLS & SNYDER LLC | 133,140 | $839,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 39,863 | $251,000 | 0.05% |
| B. Riley Wealth Advisors, Inc. | 14,428 | $91,000 | 0.01% |
| HighTower Advisors, LLC | 43,210 | $273,000 | 0.00% |
| BLAIR WILLIAM & CO/IL | 34,249 | $216,000 | 0.00% |